Medical Affairs activities are critical to adding value and enhancing a successful product lifecycle. tranScrip supports companies of all sizes with development of launch strategies, preparation and execution of publication plans, therapeutic area and product trainings, design of phase IV clinical programmes, various medical information activities and many other aspects of medical affairs.
tranScrip's Medical Affairs team has a wealth of expertise in supporting products at launch and during life-cycle management and can support a variety of pre- and post-launch and medical affairs activities, across a wide range of therapeutic areas, including orphan diseases.
Evidence-based, innovation and compliant medial affairs activities are critical for adding value and enhancing product lifecycle.
The services that tranScrip provides include, but are not limited to:
- Development of medico-marketing strategies
- Design of post-approval interventional & observational studies
- Medical input into training and/or promotional materials
- Medical information activities
- Preparation and delivery of symposia, advisory boards, etc.
- Development of publication plans and publication writing
- Therapeutic area training
- Complete virtual launch
This case study outlines tranScrip’s role in providing a Medical Affairs team to provide support at launch and beyond.
A pharma company in-licensed a new product in the final stages of regulatory approval but had no medical affairs team to support product launch.
tranScrip assembled a team comprising a medical affairs physician, a medical information specialist, a medical writer and a project manager to support peri-launch.
The product was launched as planned and a phase IV clinical trial programme was designed and initiated.